NCT04085120

Ropivacaine/Dexamethasone and 10% Lignocaine Injection in GPN Block for Intractable Cancer Pain

Comparison Between Ropivacaine/Dexamethasone and 10% Lignocaine Injection in Distal Glossopharyngeal Nerve Block for Intractable Cancer Pain- A Randomized Trial

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: All India Institute of Medical Sciences · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The study will compare the efficacy and safety of Ropivacaine/dexamethasone vs 10% lignocaine injection in distal glossopharyngeal nerve block for intractable cancer pain

Conditions

• Cancer, Oropharynx
• Pain, Intractable
• Cancer Pain

Interventions

Type	Name	Description
PROCEDURE	0.75 % Ropivacaine/ 4mg/mL dexamethasone injection	Distal glossopharyngeal nerve in the neck will be blocked by using 0.75 % Ropivacaine/ 4mg/mL dexamethasone injection
PROCEDURE	10% lignocaine injection	Distal glossopharyngeal nerve in the neck will be blocked by using 10% lignocaine injection

Timeline

• Start date: 2019-08-23
• Primary completion: 2020-01-31
• Completion: 2020-02-28
• First posted: 2019-09-11
• Last updated: 2019-09-11

Locations

1 site across 1 country: India